Tetraplegia

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

Retrieved on: 
Tuesday, October 3, 2023
Infection, Poly(methyl methacrylate), Clinic, Vertebral compression fracture, Tetraplegia, Clinical trial, PMMA, Spine, Back pain, Patient, Fracture, Risk, Amber, Entrepreneurship, Mortality, Trauma, Safety, Medical device

THE HAGUE, Netherlands, Oct. 3, 2023 /PRNewswire/ -- Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announces the official start of the clinical trials for the VCFix® Spinal System.

Key Points: 
  • THE HAGUE, Netherlands, Oct. 3, 2023 /PRNewswire/ -- Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announces the official start of the clinical trials for the VCFix® Spinal System.
  • This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures.
  • The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection.
  • Dr. Banafsheh Sajadi, Co-Founder and Chief Executive Officer, Amber Implants added "This news marks a key milestone in the product development of the VCFix® Spinal System, and we aim to expand the clinical trial to further validate the device's versatile applications.

Magic Shields, Japan, Celebrates Milestone: First US Installation in Partnership with MBK Senior Living in Orange County, CA

Retrieved on: 
Monday, October 2, 2023
Architecture, Seniors, Construction & Property, Other Manufacturing, Consumer, Interior Design, Manufacturing, Residential Building & Real Estate, Injury, Partnership, Head Injuries, Tetraplegia, Culture, Hip, Safety, Assisted living, Vibration, National Institute on Aging, Falls, Ageless, MBK, Ageing, Patent, Fracture, Risk, Independent living, Traumatic brain injury, Brain, Happiness, Shield, Subdural hematoma, Health insurance, Electrical wiring, Magic

Magic Shields' unique patent pending flooring technology employs advanced shock absorption materials to dramatically reduce the risk of injuries resulting from falls.

Key Points: 
  • Magic Shields' unique patent pending flooring technology employs advanced shock absorption materials to dramatically reduce the risk of injuries resulting from falls.
  • With the first pilot installation now in Orange County, California, Magic Shields is set to revolutionize the safety standards in a wide range of settings, from senior living facilities to children's play areas.
  • MBK, a prominent name in senior living facilities, recognized the potential of Magic Shields' revolutionary technology and agreed to test pilot the innovative flooring product.
  • Founded in 1990, MBK has focused on owning and operating Independent Living, Assisted Living, and Memory Care communities.

WillowTree Transforms Vocable AAC Mobile App with Conversational AI Integration, Giving Voice to Millions

Retrieved on: 
Thursday, September 28, 2023
Communication, Food, Boston Children's Hospital, Life, Tetraplegia, Smartphone, Speech, Internet, Stroke, Tears, ChatGPT, Human, Experiment, Blinking, OpenAI, History, MS, Hospital, One Voice Technologies, Patient, Webby Awards, Steve Way, Spectrum, MA, AAC, ALS, Caregiver, Disease, Hachette, Mobile phone, Medical device, Online shopping, Vocable

CHARLOTTESVILLE, Va., Sept. 28, 2023 /PRNewswire-PRWeb/ -- WillowTree, a leading digital experience consultancy, has launched its enhanced version of Vocable AAC with the revolutionary integration of OpenAI's ChatGPT. With 17.9 million U.S. adults experiencing difficulty speaking in the past year, this free mobile app, originally designed as an augmented and alternative communication (AAC) device for non-verbal individuals, now offers the power of conversational AI for a more intuitive and impactful method of communication.

Key Points: 
  • CHARLOTTESVILLE, Va., Sept. 28, 2023 /PRNewswire-PRWeb/ -- WillowTree, a leading digital experience consultancy, has launched its enhanced version of Vocable AAC with the revolutionary integration of OpenAI's ChatGPT.
  • The WillowTree team was motivated to create a better solution, and the result was Vocable AAC.
  • Andrew Carter, Staff Software Engineer at WillowTree, emphasizes the transformative quality of Vocable AAC's new integration: "ChatGPT is a conversational interface, it's literally made for this.
  • With Vocable AAC, WillowTree continues to give a voice to millions and remind us all of our shared human connections.

The Inner Circle Acknowledges, Harshpal Singh, MD, FAANS as a Distinguished Healthcare Professional for his contributions to the Neurological Field

Retrieved on: 
Wednesday, September 27, 2023
Spinal fusion, Icahn School of Medicine at Mount Sinai, University, Education, Tetraplegia, Neurosurgery, Laminectomy, Medical college, Neurology, Corpectomy, Medical College of Georgia, Deformity, Multimedia, Inner circle, Congress, American Board of Commissioners for Foreign Missions, Subarachnoid hemorrhage, Congress of Neurological Surgeons, American Association of Neurological Surgeons, MD, Patient, Mount Sinai School, Nerve, Myelopathy, Sport, Textbook, Neuro, Medical degree, Veterinary medicine, Dentistry, Spine, Augmented fifth, Medicine

ENGLEWOOD CLIFFS, N.J., Sept. 27, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Harshpal Singh, MD, FAANS is acknowledged as a Distinguished Healthcare Professional for his contributions to the Neurological Field.

Key Points: 
  • ENGLEWOOD CLIFFS, N.J., Sept. 27, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Harshpal Singh, MD, FAANS is acknowledged as a Distinguished Healthcare Professional for his contributions to the Neurological Field.
  • He completed a residency at Mount Sinai School of Medicine where he served as Chief Resident.
  • The doctor is also a specialist in spinal fusion; corpectomy; vertebroplasty; kyphoplasty; laminectomy; and difficult revision spinal surgery.
  • Aside from his professional pursuits, the doctor enjoys funding programs that distribute sports equipment to the disadvantaged in Punjab, India.

Implantable Medical Devices Market to grow by USD 51.1 billion from 2022-2027 | North America to account for 45% of market growth - Technavio

Retrieved on: 
Tuesday, September 26, 2023
LivaNova, Prevalence, Osteoporosis, Abbott Laboratories, Tetraplegia, Segment, National Center for Spinal Disorders, SE, Stryker Corporation, Rheumatoid arthritis, Dental implant, Gout, Hip, Zimmer Biomet, Lupus, Cardinal Health, USD, CDC, Medial knee injuries, Boston Scientific, Circulatory system, Growth, Assurant, Orthopedic surgery, Trauma, Clifton Springs Hospital & Clinic, Arthritis, Hospital, NuVasive, Research, Arthropathy, Knee, Laboratory, AbbVie, Ophthalmic, ROW, Korea Disease Control and Prevention Agency, Fibromyalgia, Medtronic, Medical device, Retail, Application, Geography

NEW YORK, Sept. 25, 2023 /PRNewswire/ -- The implantable medical devices market size is expected to grow by USD 51.1 billion from 2022 to 2027.

Key Points: 
  • NEW YORK, Sept. 25, 2023 /PRNewswire/ -- The implantable medical devices market size is expected to grow by USD 51.1 billion from 2022 to 2027.
  • Hence, such factors drive the growth of the implantable medical devices market during the forecast period.
  • Detailed information on factors that will drive the growth of the implantable medical devices market between 2022 and 2027.
  • Growth of the implantable medical devices market across North America, Europe, Asia, and ROW
    Comprehensive analysis of factors that will challenge the growth of implantable medical devices market vendors.

Leaders to Examine Health Care’s Technological Tipping Point: Northwell Health Hosts Sixth Annual Constellation Forum in NYC

Retrieved on: 
Wednesday, September 20, 2023
FDA, Technology, Pharmaceutical, General Health, Philanthropy, Medical Devices, Artificial Intelligence, Clinical Trials, Foundation, Science, Biotechnology, Software, Other Philanthropy, Health, Research, Constellation, New Frontier, Francis Crick Institute, Human, Big data, Clinton Foundation, Culture, HPE, Health care, Clinical trial, Feinstein Institutes for Medical Research, Cancer, Head, Microsoft, Medicine, Multimedia, Supercomputer, Northwell Health, Doctor of Philosophy, Ethics, MD, Patient, Tetraplegia, Frederick National Laboratory for Cancer Research, Conference on Semantics in Healthcare and Life Sciences, Artificial intelligence, AI, System, MPH, Credit, Medical research, Salesforce, Forum, Catalysis, Pfizer, European High-Performance Computing Joint Undertaking, Medical device, Management

Health care is approaching a scientific and technological tipping point, poised to cross into an age of artificial intelligence (AI) and supercomputing.

Key Points: 
  • Health care is approaching a scientific and technological tipping point, poised to cross into an age of artificial intelligence (AI) and supercomputing.
  • To explore how science, technology, culture and society are converging in medicine, Northwell Health , New York State's largest health system, will host its annual Constellation Forum .
  • View the full release here: https://www.businesswire.com/news/home/20230920880571/en/
    Michael Dowling, president and CEO of Northwell Health will host the sixth annual Constellation Forum.
  • (Credit: Northwell Health)
    Now in its sixth year, the virtual and in-person event will convene on October 5 in New York City starting at 9 a.m.

REHAB Hospital of the Pacific to Enhance Patient Care with Oracle Health's EHR

Retrieved on: 
Thursday, September 14, 2023
St. John's Rehab Hospital, Tetraplegia, Stroke, Oracle, Physical, Rehabilitation, Patient, EHR, Ecosystem, Health, Intellectual disability, Oracle Health Sciences, Conference, Caregiver, Hospital, Nursing

AUSTIN, Texas and HONOLULU, Sept. 14, 2023 /PRNewswire/ -- REHAB Hospital of the Pacific (REHAB), the only comprehensive medical rehabilitation hospital in Hawaii, is adding modules of the Oracle Health electronic health record (EHR) to all of its facilities. The modules are specific to the needs of rehabilitation facilities and is intended to support REHAB's main 82-bed campus, three outpatient clinics, and a hospital-based physicians' clinic to help treat patients with physical and cognitive disabilities including stroke and spinal cord injuries. Rehabilitation facilities are challenged with navigating limited access to data between venues and connecting care teams. Adding the EHR across the system will help deliver a more accurate clinical picture during the inpatient admission process, as well as during outpatient rehabilitation visits by providing access to both historical care data and outside medical records.

Key Points: 
  • AUSTIN, Texas and HONOLULU, Sept. 14, 2023 /PRNewswire/ -- REHAB Hospital of the Pacific (REHAB), the only comprehensive medical rehabilitation hospital in Hawaii, is adding modules of the Oracle Health electronic health record (EHR) to all of its facilities.
  • Rehabilitation facilities are challenged with navigating limited access to data between venues and connecting care teams.
  • "REHAB Hospital uses innovative models and solutions to support exemplary care and help patients rebuild their lives.
  • "With the right data at their fingertips, caregivers can be better informed to support collaborative and coordinated patient care from acute to rehab and throughout the entire healing journey.

NurExone Moves Forward Towards Human Clinical Trials, Completes Pre-IND Meeting with the FDA for Proprietary ExoPTEN Drug

Retrieved on: 
Wednesday, September 13, 2023
Communication, Tetraplegia, Drug discovery, Clinical trial, FSE, NRX, Regeneration, Patient, Exosome, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, IND, Food, Safety, Pharmaceutical industry

TORONTO and HAIFA, Israel, Sept. 13, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company” or “NurExone”), a biopharmaceutical company developing biologically-guided exosome therapy (“ExoTherapy”) for patients with traumatic spinal cord injuries, is pleased to announce that the Company has completed a Pre-Investigational New Drug (“Pre-IND”) meeting with the U.S. Food and Drug Administration (“FDA”) in connection with the manufacturing, preclinical and clinical development plan of ExoPTEN, NurExone’s first ExoTherapy product, after receiving a written response from the FDA on August 29, 2023.

Key Points: 
  • The FDA’s response indicated that the planned toxicity study strategy is acceptable under FDA guidelines and large-scale animal studies will not be required.
  • The completed Pre-IND meeting with the FDA is expected to expedite NurExone’s regulatory process to initiate Phase 1/2 human clinical studies in 2025.
  • A Pre-IND meeting offers open communication between applicants and the FDA, enabling the applicants to receive information regarding the preparation of an IND application and guidance for the clinical studies of the Company’s ExoPTEN drug.
  • The drug is being developed using NurExone’s proprietary ExoTherapy platform for producing and loading exosomes with pharmaceutical cargo targeting central nervous system injuries.

Over 200 Veterans to attend adaptive golf clinic in Iowa

Retrieved on: 
Friday, September 8, 2023
DAV, Volunteering, U.S. Department of Veterans Affairs, Office of Inspector General, Disabled American Veterans, Tetraplegia, Paratriathlon, Brain damage, Amputation, Major, United States Department of Veterans Affairs, Hospital, Veteran

RIVERSIDE, Iowa, Sept. 08, 2023 (GLOBE NEWSWIRE) -- More than 200 Veterans from around the country will take part in the 2023 National Disabled Veterans Golf Clinic, September 10–15, in and around Iowa City, Iowa.

Key Points: 
  • RIVERSIDE, Iowa, Sept. 08, 2023 (GLOBE NEWSWIRE) -- More than 200 Veterans from around the country will take part in the 2023 National Disabled Veterans Golf Clinic, September 10–15, in and around Iowa City, Iowa.
  • It serves Veterans with blindness or limited vision, spinal cord injuries, traumatic brain injuries, limb loss, and other life-changing injuries.
  • DAV (Disabled American Veterans) and the U.S. Department of Veterans Affairs co-present the five-day clinic with support from businesses, nonprofit organizations, and individual donors.
  • “The adaptive golf clinic is a great opportunity for our American heroes to play the sport they love – and take the next step in their journeys to recovery,” said Department of Veterans Affairs Secretary Denis McDonough.

Global Clot Management Devices Market Share, Trends, Opportunities, Competition, and Forecasts, 2018-2023 & 2023-2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 12, 2023
Medical Devices, Health, Surgery, General Health, Pharmaceutical, Cardiology, PE, Regional basketball competitions in Spain, Hip, Prevalence, Pulmonary embolism, Stroke, Tetraplegia, Cardiovascular disease, DVT, Ageing, Cancer, Research, Competition, Compound annual growth rate, Thrombectomy, Incidence, Hospital, AIDS, Deep vein thrombosis, Growth, Diagnosis, WHO, Smoking, Knee, World Health Organization, Medical device, Video game, Dietary supplement, Birth control

The global clot management devices market is projected to experience consistent growth with a steady Compound Annual Growth Rate (CAGR) throughout the forecast period from 2024 to 2028.

Key Points: 
  • The global clot management devices market is projected to experience consistent growth with a steady Compound Annual Growth Rate (CAGR) throughout the forecast period from 2024 to 2028.
  • Advancements in clot management device technologies aimed at enhancing the diagnosis and treatment of conditions like stroke, coupled with the increasing preference for minimally invasive medical procedures, are driving the demand for clot management devices within the market.
  • The United States commands a dominant position in the global clot management devices market.
  • Company Profiles: Detailed analysis of the major companies present in Global Clot Management Devices Market.